Tak-Wah Mak
Founder at Tio Bioventures
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mark Bray | M | 58 |
Miikana Therapeutics, Inc.
 Miikana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Miikana Therapeutics, Inc. develops therapeutics for the treatment of cancer and inflammatory diseases. It is a biopharmaceutical company focused on development and discovery of novel oncology drugs. It also performs its own research and licenses other companies. The company was founded in 2002 by Tak Mak, Dinesh Patel and S. Gail Eckhardt and is headquartered in Fremont, CA.
Tio Bioventures
 Tio Bioventures Investment ManagersFinance Tio Bioventures (Tio Bioventures) is a venture capital firm founded in 2019 by Tak Wah Mak and Shane Burgess. The firm is headquartered in New York. | 10 years |
| Shane Burgess | M | - |
Tio Bioventures
Tio Bioventures Investment ManagersFinance Tio Bioventures (Tio Bioventures) is a venture capital firm founded in 2019 by Tak Wah Mak and Shane Burgess. The firm is headquartered in New York. | 5 years |
| Michael W. Tusche | M | - |
Tio Bioventures
Tio Bioventures Investment ManagersFinance Tio Bioventures (Tio Bioventures) is a venture capital firm founded in 2019 by Tak Wah Mak and Shane Burgess. The firm is headquartered in New York.
University of Toronto
| 1 years |
| Anthony Neri | M | - |
Miikana Therapeutics, Inc.
Miikana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Miikana Therapeutics, Inc. develops therapeutics for the treatment of cancer and inflammatory diseases. It is a biopharmaceutical company focused on development and discovery of novel oncology drugs. It also performs its own research and licenses other companies. The company was founded in 2002 by Tak Mak, Dinesh Patel and S. Gail Eckhardt and is headquartered in Fremont, CA. | - |
| Colleen Paige | F | - |
Miikana Therapeutics, Inc.
Miikana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Miikana Therapeutics, Inc. develops therapeutics for the treatment of cancer and inflammatory diseases. It is a biopharmaceutical company focused on development and discovery of novel oncology drugs. It also performs its own research and licenses other companies. The company was founded in 2002 by Tak Mak, Dinesh Patel and S. Gail Eckhardt and is headquartered in Fremont, CA. | - |
| Ryan Dietz | M | - |
Tio Bioventures
Tio Bioventures Investment ManagersFinance Tio Bioventures (Tio Bioventures) is a venture capital firm founded in 2019 by Tak Wah Mak and Shane Burgess. The firm is headquartered in New York. | 4 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stuart R. Nayman | M | - |
University of Toronto
| 7 years |
| Dinesh Patel | M | 67 |
Miikana Therapeutics, Inc.
Miikana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Miikana Therapeutics, Inc. develops therapeutics for the treatment of cancer and inflammatory diseases. It is a biopharmaceutical company focused on development and discovery of novel oncology drugs. It also performs its own research and licenses other companies. The company was founded in 2002 by Tak Mak, Dinesh Patel and S. Gail Eckhardt and is headquartered in Fremont, CA. | 2 years |
| Joseph Cargnelli | M | 54 |
University of Toronto
| 6 years |
| Dwight Bush | M | 67 |
CASI Pharmaceuticals, Inc. /Old/
 CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | 10 years |
| Yaroslava Teslya | F | - |
University of Toronto
| 6 years |
| Michael Dolega | M | - |
University of Toronto
| 7 years |
| Peter Van Michaels | M | - |
University of Toronto
| 7 years |
| Jon Case | M | - |
University of Toronto
| 6 years |
| Yuri Sagalov | M | - |
University of Toronto
| 5 years |
| Alexandre Pernin | M | - |
University of Toronto
| 5 years |
| Kelly Battle | F | - |
University of Toronto
| 7 years |
| Fiona J. Kelly | F | - |
University of Toronto
| 3 years |
| Claudia Krywiak | M | - |
University of Toronto
| 3 years |
| James Hughes | M | - |
University of Toronto
| 6 years |
| Adam Cilio | M | - |
University of Toronto
| 6 years |
| Grant Connor | M | - |
University of Toronto
| 4 years |
| Brendan Cochrane | M | - |
University of Toronto
| 7 years |
| Trevor Young | M | - |
University of Toronto
| 5 years |
| Claire Kennedy | F | 57 |
University of Toronto
| 9 years |
| Zachary Newton | M | 40 |
University of Toronto
| 4 years |
| Betty Yang | F | - |
University of Toronto
| 5 years |
| Cory Mulvihill | M | - |
University of Toronto
| 10 years |
| Lillian Zhang | F | - |
University of Toronto
| 10 years |
| Scott McAuley | M | - |
University of Toronto
| 9 years |
| Shubo Yan | M | - |
University of Toronto
| 5 years |
| Greg Payne | M | - |
University of Toronto
| 14 years |
| Eric Ng | M | - |
University of Toronto
| 7 years |
| Roger Ferreira | M | - |
University of Toronto
| 7 years |
| Yousef Rehman | M | 42 |
University of Toronto
| 7 years |
| Ronan Levy | M | 45 |
University of Toronto
| 7 years |
| Andrzej Jankowski | M | - |
University of Toronto
| 9 years |
| Ka Yan Lau | M | 55 |
University of Toronto
| 6 years |
| Jonathan Anschell | M | 56 |
University of Toronto
| 6 years |
| He Yu | M | 67 |
University of Toronto
| 5 years |
| George Babu | M | - |
University of Toronto
| 15 years |
| Sandy Der | M | - |
University of Toronto
| 13 years |
| Quan Zhou | M | 66 |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | - |
| Jeremy Rakusin | M | 55 |
University of Toronto
| 4 years |
| Mark Steele | M | - |
University of Toronto
| 8 years |
| Zuie Chin Huang | M | 58 |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | - |
| John Maletic | M | - |
University of Toronto
| 7 years |
| Arjun Kumar | M | - |
University of Toronto
| 8 years |
| Stefan Ioannou | M | - |
University of Toronto
| 10 years |
| Tom Meyer | M | 56 |
University of Toronto
| 6 years |
| John Tobia | M | - |
University of Toronto
| 6 years |
| Wei Wu He | M | 59 |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | - |
| Rajesh Shrotriya | M | 79 |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | - |
| Mark Corbet MacRae Randall | M | 61 |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | 17 years |
| Bryan Edwin Rock | M | 45 |
University of Toronto
| 7 years |
| Paul Gorman | M | - |
University of Toronto
| 5 years |
| Scott Warlow | M | - |
University of Toronto
| 5 years |
| Ted Tjaden | M | - |
University of Toronto
| 3 years |
| Elaine Ellingham | F | 65 |
University of Toronto
| 4 years |
| Ken Keyong Ren | M | 64 |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | 7 years |
| Yue Wu | M | 62 |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | - |
| Franklin Salisbury | M | 68 |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | - |
| John Docherty | M | 53 |
University of Toronto
| 6 years |
| Kate Kocur | F | - |
University of Toronto
| 5 years |
| Paolo Lostritto | M | 50 |
University of Toronto
| 4 years |
| Feng Li | F | 35 |
University of Toronto
| 4 years |
| Catherine Elizabeth Payne | F | - |
University of Toronto
| 4 years |
| Hiyam Jibry | M | - |
University of Toronto
| 4 years |
| Parm Kalirai | M | - |
University of Toronto
| 4 years |
| Paul Gill | M | - |
University of Toronto
| 1 years |
| Trent Webster | M | - |
University of Toronto
| 2 years |
| Tsun Yu Lo | M | 39 |
University of Toronto
| 4 years |
| Jack M. Mintz | M | 72 |
University of Toronto
| 2 years |
| Jim Athanasopoulos | M | 54 |
University of Toronto
| 4 years |
| Jason Chin | M | - |
University of Toronto
| 2 years |
| Paul Chavez | M | - |
University of Toronto
| 4 years |
| Fook Chi Wong | F | 40 |
University of Toronto
| 4 years |
| Elisabeth DeMarco | F | 56 |
University of Toronto
| 1 years |
| Anton B. Diener | M | - |
University of Toronto
| 4 years |
| Paul Lin | M | 61 |
University of Toronto
| 3 years |
| Sachin Shah | M | 47 |
University of Toronto
| 4 years |
| Kelvin Hu | M | - |
University of Toronto
| 1 years |
| Rakesh V. Advani | M | - |
University of Toronto
| 4 years |
| Ehsan Zargar | M | 47 |
University of Toronto
| 4 years |
| Klara Gotz | F | - |
University of Toronto
| 4 years |
| John R. G. Challis | M | 77 |
University of Toronto
| 13 years |
| Matt Bank | M | - |
University of Toronto
| 1 years |
| Kurtis A. Tunnell | M | - |
University of Toronto
| 1 years |
| Karen Ko | F | - |
University of Toronto
| 2 years |
| Eric Hsu | M | - |
University of Toronto
| 3 years |
| Siew Ching Yeo | F | - |
University of Toronto
| 4 years |
| Damian Tam Hoang | M | - |
University of Toronto
| 5 years |
| Francois du Toit | M | - |
University of Toronto
| 4 years |
| Suneet Singh Tuli | M | 54 |
University of Toronto
| 4 years |
| Colin White | M | - |
University of Toronto
| 4 years |
| Warren Louis Tang | M | 47 |
University of Toronto
| 4 years |
| Yatika Kohli | M | - |
University of Toronto
| 3 years |
| Cecilia Williams | F | 47 |
University of Toronto
| 4 years |
| Regina Wong | F | - |
University of Toronto
| 4 years |
| Heather Takahashi | F | - |
University of Toronto
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 85 | 85.00% |
| United States | 16 | 16.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Tak-Wah Mak
- Personal Network
